Pharma Tech

Ona Therapeutics to develop ADC with WuXi’s payload-linker platform

Sep 18, 2026, 9:39 AM

Read Full Article → Ona Therapeutics to develop ADC with WuXi’s payload-linker platform

Translate article text

Choose a language and wait for the translated text.

WuXi XDC Cayman is to provide Ona Therapeutics with an exclusive global licence to its WuXiTecan-2 platform to develop an ADC candidate.